Exenatide
Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
AstraZeneca · Phase 3 · Status n/r · Enrollment 150
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Liraglutide | n/r | n/r | n/r | n/r | n/r |
| Exenatide | n/r | n/r | n/r | n/r | n/r |
| Exenatide Microspheres for Injection | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.